Cardiac involvement in infantile Sandhoff disease

P Venugopalan1, S N Joshi

  • 1Department of Child Health, Sultan Qaboos University Hospital, Muscat, Oman. gopalax@omantel.net.om

Insights

This report details an infant with Sandhoff disease, highlighting neurological symptoms alongside severe mitral regurgitation and aortic regurgitation due to valve prolapse. The case also presents unusual interventricular septum hypertrophy.

Area of Science:

  • Biochemistry
  • Genetics
  • Cardiology

Background:

  • Sandhoff disease is a rare, fatal neurodegenerative lysosomal storage disorder.
  • Infantile Sandhoff disease typically presents with severe neurological impairment.

Purpose of the Study:

  • To report a case of infantile Sandhoff disease with unusual cardiac manifestations.
  • To highlight the importance of comprehensive evaluation in Sandhoff disease.

Main Methods:

  • Enzyme assay for Sandhoff disease confirmation.
  • Clinical examination for neurological and cardiac assessment.
  • Echocardiography to evaluate cardiac structure and function.

Main Results:

  • Enzyme assay confirmed infantile Sandhoff disease.
  • Patient exhibited classical neurological features.
  • Severe mitral regurgitation secondary to mitral valve prolapse and mild aortic regurgitation from aortic valve prolapse were observed.
  • Asymmetric hypertrophy of the interventricular septum was noted without left ventricular outflow tract obstruction.

Conclusions:

  • Sandhoff disease can present with significant cardiac abnormalities beyond neurological symptoms.
  • Early recognition and management of cardiac complications are crucial in patients with Sandhoff disease.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...